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Although environmental contaminants have potential to affect breast cancer risk, explicit
environmental links to this disease are limited. The most well-defined environmental risk factors
are radiation exposure and alcohol ingestion. Diet is clearly related to the increased incidence of
breast cancer in developed countries, but its precise role is not yet established. Recent studies
have implicated exposure to organochlorines including DDT as a risk factor for breast cancer in
the United States, Finland, Mexico, and Canada. Other investigations have discovered
associations between breast cancer risk and exposures to chemical emissions and some
occupational exposures. Several points must be considered in evaluating the relationship of
environmental exposure to breast cancer. Among these considerations are the mechanism of
tumorigenesis, timing of environmental exposure, and genetic modulation of exposure.
Epidemiologic and ecologic investigations must take into account the very complex etiology of
breast cancer and the knowledge that tumorigenesis can arise from different mechanisms. Thus
crucial exposures as well as reproductive events related to breast cancer may occur years before
a tumor is evident. Moreover, environmental contaminants may alter reproductive development,
directly or indirectly, and thereby affect the course of tumorigenesis. Such alterations include
change in gender, change in onset of puberty, and inhibition or promotion of tumor formation.
Timing of exposure is therefore important with respect to mechanism and susceptibility. Finally,
genetic polymorphisms exist in genes that govern capacity to metabolize environmental
contaminants. Higher risk may occur among persons whose enzymes either are more active in
the production of procarcinogens or fail to detoxify carcinogenic intermediates formed from
chemicals in the environment. Environ Health Perspect 105(Suppl 4):891-896 (1997)
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Introduction
strong association, although significant risks
have been identified in some reports (5).
However, a similar relationship between
international incidence ofcolon cancer and
dietary fat intake has been confirmed in
subsequent studies (2). Moreover, certain
kinds offat may be protective: olive oil
consumption, for example, has been associ-
ated with reduced risk ofbreast cancer (6).
Therefore, it may be argued that the mea-
surement of dose as fat intake requires
greater precision in epidemiologic studies
ofbreastcancer.
Likewise, our inability to quantitate
exposure in studies ofthe environmental
etiology of the disease may explain the
lack of substantive evidence on environ-
mental exposures and risk of breast
cancer. Two notable exceptions exist.
Evidence for risk of breast cancer from
exposure to ionizing radiation is quite
strong, and risk associated with alcohol
intake has gained acceptance (Table 1).
Mechanistic Considerations
In the 1950s, Armitage and Doll (7)
advanced the theory ofmultistage carcino-
genesis, based on the observed slope ofsix
for log-incidence versus log-age curves
(Figure 1). The curves seen are similar for
premenopausal breast cancer and a number
ofother cancers, including colon cancer.
However, a marked drop in slope around
Breast cancer is the most common malig-
nancy among women in the United States
and in western Europe. Approximately
500,000 women worldwide and 150,000
women in the United States areaffected each
year, yetwe cannot explain its causes nor can
wepredictwho will bediagnosedwith breast
cancer. The major risk factors for breast
cancer are age, country ofbirth, and family
history. Many other acknowledged risk fac-
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Abbreviations used: DES, diethylstilbestrol;
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nitrosourea; NAT, N-acetyl transferase; PAHs, poly-
cyclic aromatic hydrocarbons; PCBs, polychlorinated
biphenyls; RFLP, restriction fragment length polymor-
phism; TCDD, 2,3,7,8-tetrachlorodibenzodioxin.
tors can be traced to reproductive events that
influence lifetime levels ofhormones. A
recent report identified 41 to 47% ofrisk
to be explained by one's age at the time of
first complete pregnancy, family history,
and income (1).
Wide variations have long been noted
in international incidence in breast cancer,
and differences also exist between ethnic
groups (2). In addition, breast cancer rates
internationally have risen dramatically in
recent years, and not all ofthe increase is
explained by enhanced screening (3).
These observations suggest that environ-
mental factors playa role in one or more of
the possible pathways leading to carcino-
genesis. Environmental exposures can be
prevented; therefore, we should pay close
attention to potential environmental causes
ofbreast cancer.
Rose et al. (4), among others, noted a
correlation between international incidence
ofbreast cancers and a country's average fat
intake. In subsequent analytical studies,
this relationship has not proved to be a
Table 1. Alcohol use and radiation exposure: known
environmental riskfactorsfor breastcancer.
Exposure Relative risk
Alcohol (>3 drinks perday) 1.3
Radiation (atomic bomb 2-6
or intense radiationtherapy)
Data from John and Kelsey(59).
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Figure 1. Age-specific incidence of breast and colon
cancer per hundred thousand women, 1969 to 1971.
Data from Pike et al. (8).
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Figure 2. Proposed model of progression in multistage breasttumorigenesis. [AfterVogelstein (9)]
age 50, corresponding to age ofmenopause,
signifies the dramatic impact of ovarian
hormones on the occurrence of breast
cancer (8).
By analogy to Vogelstein's detailed view
ofcolon cancer (9), multiple steps lead to
breast cancer, beginning with initiation and
followed by promotion. These changes may
include mutations in oncogenes and tumor-
suppressor genes (Figure 2), steps that can
be induced by DNA mutations from envi-
ronmental exposures. Tumor growth may
be promoted by exposure to endogenous
hormones or exogenous environmental
hormone mimics.
Family history of breast or ovarian
cancer constitutes a well-known risk factor
for breast cancer. However, family history
accounts for only 5 to 10% ofthe incidence
ofbreast cancer (1). Szabo and King (10)
consider inheritance of mutations in
BRCA1, BRCA2, p53, ataxia telangiectasia,
androgen receptor, rasand estrogen receptor
to be important risk factors. Variants among
some ofthese genes are thought to explain
familial breast cancer risk. However, inher-
ited mutations in these genes altogether
contribute less than 15% to breast cancer
risk. In addition, not all women who inherit
an aberration in BRCAI develop breast
cancer, which suggests that a gene-environ-
ment or gene-gene interaction may be
responsible for its ultimate effect (11,12).
Other genetic factors may be more
important, especially in terms ofgene-envi-
ronment interactions. In particular, certain
enzymes have the potential to metabolize
environmental agents to procarcinogens
and ultimate carcinogens. These proteins
are polymorphic and some variants are
more or less efficient for activation or
detoxification (Table 2). The prevalence of
specific variants may further vary by eth-
nicity (Table 2), and one report has found
an increased risk of breast cancer among
African-American women who harbor an
MsPI variant in CYPIAI (13). Additional
risk may arise when specific exposures are
experienced by individuals with an at-risk
genotype. For example, Ambrosone et al.
(14) have reported greatly elevated risk
among women who were slow acetylators
(deficient in NAT2) who also had a long
history ofheavy cigarette smoking. This is
consistent with observations that persons
who lack the capacity to acetylate aromatic
amines are at greater risk for bladder cancer
following exposure to aniline dyes (15).
Tumor Initiators
Chemical carcinogens may be broadly clas-
sified as initiators or promoters. Laboratory
studies offer many clues to possible envi-
ronmental etiology ofbreast cancer. In vivo
studies show that tumors can be initiated
and promoted in rodents by different
classes ofchemicals that represent impor-
tant classes of environmental pollutants,
for example polycyclic aromatic hydrocar-
bons PAHs and polychlorinated biphenyls
PCBs. In vitro experiments show that
chemicals in the environment can cause
genetic damage, modulate cell prolifera-
tion, bind to hormone receptors, and
regulate enzyme activity.
As many as 160 chemicals cause mam-
mary tumors in rodents (16). Dimethyl-
benzanthracene (DMBA) and dimethyl-
nitrosourea (DNU) are classic mammary
tumor initiators in rodents. A number of
these, primarily initiators that cause DNA
mutations, are also well-recognized environ-
mental contaminants: ethylene dibromide,
vinyl chloride, carbon tetrachloride,
dichloromethane, diethylstilbestrol (DES),
estradiol, methylnitrosourea, 3-methyl-
cholanthrene, and DMBA (16). However,
little evidence exists to support these chemi-
cals as breast carcinogens in humans. For
solvents and PAHs, a few ecologic studies
(17-19) and correlations with occupa-
tional exposures (20-22) are consistent
with the experimental data; however, these
observations do not provide convincing
evidence linking chemical exposures to
breast cancer. Our failure to find associa-
tions in humans that reflect the experimen-
tal findings may be attributed in part to
our inability to adequately characterize
exposure. In general, current epidemiologic
methods are not able to measure exposure
at the actual time of tumor initiation,
which occurs 20 to 40 years before diagno-
sis, because most chemical agents do not
persist long in the body.
Timing of Exposures
An essential characteristic of the model
for mammary tumorigenesis (Figure 2) is
that the time at which exposures occur is
Table 2. Allelic frequencies of some Phase and Phase II metabolism genes.
Frequency of minorallele
Gene/RFLP Caucasian Asian African American Other Reference
CYPlAl
/Msplorlle -val 0.10 0.33a 0.22 - (60)
0.11 - 0.22 - (13)
CYP1A2(phenotype) 0.41 - - - (61)
0.38 0.22 - - (62)
CYP2E1 (63)
/Dral 0.08 0.31a 0.09 - (64)
/Rsal or/Pstl 0.02 0.25a 0.02-0.05 - (65)
GST-p null 0.54 0.45 0.13 0.48b (66,67)
GST-0 null 0.20 0.64c 0.22 0.1d (68)
NAT2 any, null = less 0.74 0.52ae 0.59 0.57b (69)
NAT2 null 0.56 - 0.41 - (70)
NAT2 slow phenotype 0.50 NS - - (62)
0.30 S - - - (62)
NAT2 phenotype 0.54 0.14 0.34 - (15)
Abbreviations: RFLP, restriction fragment length polymorphism; GST, glutathione S-transferase; NS, nonsmoker;
S, smoker. "Japanese. bHispanic. cKorean. dMexican. "Chinese.
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important. Animal models clearly demon-
strate that initiating exposures (e.g.,
DMBA, DNU) are most effective when
they occur early in life, at a time when
breast epithelium is proliferating (23).
Similar evidence in humans is scarce, but
supports the view that timing ofexposures
is critical. Age at reproductive milestones is
widely acknowledged to be relevant to
breast cancer risks; thus it is dear that early
menarche, late pregnancy, and late
menopause confer risk. For environmental
exposures, radiation exposure at an early
age (younger than 20 years) imparts a high
risk oflater breast cancer, while exposures
among women over 40 years ofage show
modest increased risk (Table 3) (24).
Similarly, cigarette smoking, which has not
been an accepted risk factor for breast
cancer, in some studies is associated with
greater risk among women who began
smoking at an early age (25).
Tumor Promotion
and Hormonal Activity
Promotion of mammary cancer by
environmental agents is suspected to occur
because many ofthese chemicals behave in
vivo and in vitro much like estrogen. Plant
derivatives, pesticides, and plasticizers have
been reported to mimic hormones. These
compounds bind to the estrogen receptor
(26), induce tumor-cell proliferation (27),
and promote mammary tumor formation
in rodents (28,29). The hallmark ofestro-
gen response in the rodent is increased uter-
ine weight, an effect observed with a wide
range ofenvironmental agents (Table 4).
Table 3. Radiation and breast cancer risk among
atomic bomb survivors.
Age at radiation Relative risk
exposure years atdose of 1 SV
40-60 1.6
20-40 2.2
10-20 3.1
<10 4.0
Data from Tokunaga et al. (24).
Table 4. Effects on age at puberty and cyclicity of
chemical treatment in the rat.
Vaginal openinga Acyclicity
Coumestrol Normal: Premature:
35versus 35 days 83% day 135
Aroclor 1221 Early: Premature:
28versus 42 days 64% day 180
TCDD Never: 80% Irregularity
"Puberty. Data from Whitten et al. (71); Gellert (72);
Grayand Ostby(73); Li etal. (74).
During gestation or early life, estrogenlike
exposures accelerate female development.
Uterine weight gain is caused by treatment
with estrogen, DES, o,p'-DDT, coume-
strol, equol, bourbon extracts, methoxy-
chlor, chlordecone (kepone), and the
following PCBs: Aroclor 1221, 1232,
Aroclor 1242, Aroclor 1248, 2,2',5,5'-
tetrachlorobiphenyl, 2-chlorobiphenyl,
2,2'-dichloroiphenyl,2,2',4,4',6,6'-hexa-
chlorobiphenyl, and 4-hydroxy-2',4',6'-
trichlorobiphenyl. Uterine weight loss
is induced by treatment with BHC
and 2,3,7,8,-tetrachlorodibenzodioxin,
dioxin (TCDD) (26,30-39). In wildlife,
feminization of alligators (40) has been
attributed to organochlorine exposures.
Experimental studies in turtles have elicited
male-to-female gender alterations with
exposure to PCB metabolites (41).
Several reports have suggested an
association between exposure to DDT and
breast cancer risk (42-44). In these studies,
persistent organochlorines were determined
in individual women, providing an inte-
grated measure oflong-term internal dose.
Several epidemiologic studies are underway
to darify the relationship ofDDT exposure
to breast cancer. Observations ofcurtailed
lactation among women with elevated
DDT exposures (Figure 3) suggest that
organochlorines can exert hormonal effects
in humans.
In contrast, other compounds, induding
TCDD, are antiestrogenic (45) and inhibit
tumor growth in rodents (46,47). Exposure
to TCDD delays onset of puberty in
female rodents and reduces uterine weight
(Table 4 and above).
Though quite limited, data in humans
are consistent with the antiestrogenic
effects ofTCDD. In young men exposed
perinatally to dioxinlike PCBs and poly-
chlorinated dibenzofurans, delayed devel-
opment of male reproductive organs has
10
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Figure 3. Duration of lactation in months according to
level of DDE in breast milk lipids. Data from Gladen
and Rogan (75) and Rogan et al. (76).
been observed (48). Deficits ofbreast and
uterine cancer have been seen in Seveso,
Italy, during 10 years following an indus-
trial accident that produced TCDD emis-
sions (49). Other reports, however, suggest
elevated breast cancer mortality among
women with longer term exposure to
TCDD (50,51). Thus it may be that short
term exposure to TCDD is protective,
while long-term exposure to dioxin, which
is otherwise a potent animal carcinogen,
enhances breast cancer risk.
Experimental data on PCBs indicate
that these compounds may produce either
agonist or antagonist responses in hor-
monal systems. Both structure and relative
rate ofmetabolism, i.e., biological half-life,
control what hormonal effects may occur
in humans (52). Structure determines
receptor binding affinity, while metabolism
dictates how long biological effects last in
the body. Therefore, certain PCBs are
estrogenic but are rapidly excreted and
their effects last for only a few months
after a single exposure; other PCBs (and
TCDD) are antiestrogenic and have half-
lives of several years. Some PCBs have
estrogenic potential in animals onlythrough
their metabolites (53). Moreover, PCBs
and other organochlorines may interact
synergistically with the estrogen receptor,
perhaps through multiple binding sites on
this receptor (54).
Soy and other foods, includinglegumes,
are rich in the isoflavone phytoestrogens
(genistein, daidzein, coumestrol). These
compounds have a broad range ofpotential
anticancer effects, as estrogen agonists and
antagonists, as antioxidants, by inhibiting
aromatase enzymes, and by altering serum
hormone building properties. Countries
with diets high in soy generally have low
breast cancer incidence, which has been
attributed to lower levels ofsteroid hor-
mones among women residing in these
areas (55). Lower hormone levels and
reduction in cancer risk may result from a
combination offactors, including a high
fiber, low fat, low calorie diet as well as
high levels ofphytoestrogens and antioxi-
dants. In Singapore, an investigation of
dietary components related to breast cancer
risk suggested that high soy intake was
protective and that meat intake was a risk
factor (56).
The hormonal activity of soy con-
stituents has been widely studied, and
recent findings show that single isoflavones
can be either estrogenic or antiestrogenic
in different circumstances. Whether an
agonist or antagonist affects results is
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dependent upon the dose level (high or
low) and the timing ofexposure. Genistein,
an isoflavone found in soy products,
inhibits mammary tumorigenesis in rats
(57). Coumestrol, like antiestrogenic PCBs
and TCDD, causes premature anovulation
in rats, whereas an estrogenic PCB (Aroclor
1221) or DDT can hasten the onset of
puberty (Table 4). Another isoflavone,
zearalenone, given to mice before day 5 of
age delays puberty but after day 5 causes
earlier onset ofpuberty (58).
Understanding the chemical interac-
tions and the lifelong hormonal implica-
tions ofenvironmental exposures requires
careful attention to onset, duration, and
toxicokinetic characteristics of chemical
agents. Mixtures normally occur in the
environment such that populations are not
exposed to a single chemical moiety, but
interactions of chemicals in the body are
not well understood. Simple additive
models may approximate biological effects
at one moment of exposure, but such
models cannot take into account relative
rates ofmetabolism, susceptibility due to
inherited metabolic capacity, susceptibility
due to breast epithelial development, or
synergistic interactions ofchemicals.
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